Evidence map›Paper›PMID 42773138›Full record

ArticleNature communications2026

Generative AI designs functional thiolation domains for reprogramming non-ribosomal peptide synthetases.

Emre F Bülbül, Seounggun Bang, Kevin George, Gabriele Bianchi, Prateek Raj, Seonyong Chung, Vincent Pauline, Ramon Hochstrasser, Hannah A Minas, Walid A M Elgaher and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Emre F Bülbül *Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.
Seounggun Bang *Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.ORCID http://orcid.org/0009-0001-2964-3259
Kevin George *Center for Bioinformatics, Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0009-0006-4857-665X
Gabriele BianchiHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.
Prateek RajDepartment of Molecular Structural Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Seonyong ChungHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.
Vincent PaulineTechnical University of Munich - Helmholtz AI - Munich Center for Machine Learning (MCML), München, Germany.
Ramon HochstrasserMyria Biosciences AG, Basel, Switzerland.
Hannah A MinasMyria Biosciences AG, Basel, Switzerland.ORCID http://orcid.org/0000-0003-2997-6915
Walid A M ElgaherHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.ORCID http://orcid.org/0000-0002-8766-4568
Andreas M KanyHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.ORCID http://orcid.org/0000-0001-7580-3658
Anna K H HirschHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.ORCID http://orcid.org/0000-0001-8734-4663
Steven SchmittMyria Biosciences AG, Basel, Switzerland.
Dirk W HeinzDepartment of Molecular Structural Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID http://orcid.org/0009-0006-0514-1728
Olga V KalininaHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany.ORCID http://orcid.org/0000-0002-9445-477X
Dietrich KlakowSpoken Language Systems (LSV), Saarland University, PharmaScienceHub (PSH), Saarbrücken, Germany.ORCID http://orcid.org/0000-0002-4147-9690
Kenan A J BozhüyükHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarbrücken, Germany. kenan.bozhueyuek@helmholtz-hips.de.ORCID http://orcid.org/0000-0002-8609-2967

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large language models and generative protein design promise to accelerate biotechnology, but it remains unclear whether they can engineer dynamic megasynth(et)ases whose activity depends on transient, context-specific domain interfaces. Non-ribosomal peptide synthetases (NRPSs) exemplify this challenge and produce many clinically used therapeutics. Here we integrate pretrained generative models (ESM3, ProteinMPNN and EvoDiff) with design-build-test-learn cycles and data-guided prioritization to generate 76 de novo thiolation (T) domains. We build and test 578 recombinant NRPS variants in vivo spanning minimal, full-length, and hybrid assembly lines. AI-designed T-domains support product formation across architectures, enable catalytically active hybrids at recombined junctions, and increase yields by up to ~3-fold relative to NRPSs carrying the native T-domain. A representative design shows improved soluble expression, refolding, and a 12 °C higher melting temperature, while molecular dynamics simulations indicate preserved global stability but reshaped, state-dependent interdomain contact networks. Together, these results establish generative design as an effective route to context-conditioned engineering and reprogramming of biosynthetic assembly lines.

Indexed as

Peptide SynthasesProtein EngineeringSulfhydryl CompoundsEscherichia coliGenerative Artificial IntelligenceLarge Language ModelsMolecular Dynamics SimulationProtein DomainsRecombinant Proteinsnon-ribosomal peptide synthasePeptide SynthasesRecombinant ProteinsSulfhydryl Compounds

Identifiers

PMID42773138
PMCPMC13598123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.